85 results
8-K
EX-1.1
LCTX
Lineage Cell Therapeutics Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
, conducted or issued, any recall, market withdrawal or replacement, safety alert, post sale warning, “dear healthcare provider” letter, or other notice
425
EX-2.1
mu3r96e 5uxr
8 Nov 18
Business combination disclosure
6:41am
8-K
EX-2.1
f4fevs5218q
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
424B5
qlbd4dpf29p07ib dsc
14 Sep 15
Prospectus supplement for primary offering
12:00am